Article
Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.
Leukemia - 1 Jun 2024
Awada Hussein, Gurnari Carmelo, Visconte Valeria, Durmaz Arda, Kuzmanovic Teodora, Awada Hassan, Tu Zheng Jin, Cook James R, Bolwell Brian J, Sobecks Ronald, Kalaycio Matt, Bosler David, Maciejewski Jaroslaw P
Abstract excerpt
Therapy-related myeloid neoplasms (tMN) are complications of cytotoxic therapies. Risk of tMN is high in recipients of autologous hematopoietic stem cell transplantation (aHSCT). Acquisition of genomic mutations represents a key pathogenic driver but the origins, timing and dynamics, particularly in the context of preexisting or emergent clonal hematopoiesis (CH), have not been sufficiently clarified. We studied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
